EMEA-001198-PIP02-16

Key facts

Invented name
Akynzeo
Active substance
  • Fosnetupitant
  • Palonosetron
Therapeutic area
Other
Decision number
P/0358/2016
PIP number
EMEA-001198-PIP02-16
Pharmaceutical form(s)
Powder for solution for infusion
Condition(s) / indication(s)
Prevention of chemotherapy-induced nausea and vomiting
Route(s) of administration
Intravenous use
Contact for public enquiries
Helsinn Birex Pharmaceuticals Limited
Switzerland
E-mail: paediatrics-netu@helsinn.com
Tel.: +41 919851950
Fax: +41 919852195
Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating